Thrombocytopenia due to escitalopram use - A rare case report at the emergency department
Iraqi Journal of Hematology, cilt.10, sa.1, ss.79-81, 2021 (ESCI, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 10 Sayı: 1
- Basım Tarihi: 2021
- Doi Numarası: 10.4103/ijh.ijh_47_20
- Dergi Adı: Iraqi Journal of Hematology
- Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus
- Sayfa Sayıları: ss.79-81
- Anahtar Kelimeler: Escitalopram, selective serotonin reuptake inhibitor, thrombocytopenia
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
Selective serotonin reuptake inhibitors are commonly used in the treatment of many psychiatric diseases today. Their common side effects consist of gastrointestinal side effects, sexual dysfunction, headache, insomnia, and sedation, whereas hematological side effects have been reported, although rarely. In this article, we presented a case of thrombocytopenia, which is a rare side effect emerging after the escitalopram use, belonging to a 19-year-old female patient who had a generalized anxiety disorder and no hematological history was noted. We aimed to discuss the development mechanism of thrombocytopenia due to the escitalopram use.